Is Winston Pharmaceuticals Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Winston Pharmaceuticals Inc (WPHM) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Winston Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Winston Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Winston Pharmaceuticals Inc?

Muslim investors may consider investing in Winston Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Winston Pharmaceuticals Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Winston Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Winston Pharmaceuticals Inc updated?

The Shariah compliance status of Winston Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Winston Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Winston Pharmaceuticals Inc?

You can check the latest Shariah compliance status of Winston Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Winston Pharmaceuticals Inc. Stock Analysis WPHM

United States Health Care Nano Cap

Winston Pharmaceuticals, Inc. operates as a pharmaceutical company which engages in the discovery and development of products for pain management. The company is headquartered in Vernon Hills, Illinois and currently employs 9 full-time employees. The company went IPO on 2006-02-23. The firm discovers, develops and commercializes therapeutics for managing and alleviating pain. The firm's late stage candidates include products for the treatment of episodic cluster headache, chronic migraine headache, osteoarthritis, rheumatoid arthritis, neuropathic pain, and pain and inflammation in inflammatory bowel disease. The firm is developing Civamide, which is a transient receptor potential channels vanilloid-1 (TRPV-1) modulator in different dosage forms for several different pain indications. The firm's other products are under development for the treatment of headache and neuropathic and rheumatological pain.

Financial Metrics & Statements of Winston Pharmaceuticals Inc (WPHM)

FAQ's for Winston Pharmaceuticals Inc (WPHM)

According to Musaffa’s Shariah screening methodology, Winston Pharmaceuticals Inc (WPHM) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.